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Abstract
Background: The spread of resistance to carbapenems among Enterobacteriaceae has become a major public
health problem in recent years. In this study, we describe an outbreak of Klebsiella pneumoniae in the neonatal
ward. First, we aimed to study the drug resistance, genetic relatedness, and transmission mechanism of
carbapenem-resistant K. pneumoniae; second, we implemented infection control measures to contain the
outbreak.
Methods: We investigated 27 non-repetitive strains isolated from neonates and five strains cultured from
around the neonatal ward. Polymerase chain reaction (PCR), the agar dilution method, and multilocus
sequence typing (MLST) were used to analyze the resistance gene(s), antimicrobial susceptibility, and
homology, respectively. Health-care personnel education, hand hygiene, outer gown changing, and
infected patient isolation were strictly enforced.
Results: Our antimicrobial susceptibility results show that all strains were multidrug-resistant. MLST and PCR
results revealed that, in this study, all of the KPC-2-producing strains are Sequence Type (ST) 11 (ST11) (n = 22)
and all of the NDM-1-producing strains are ST20 (n = 4) or ST888 (n = 1). The environmental strains were
identified as KPC-2-positive K. pneumoniae ST11 (n = 3) and NDM-1-positive K. pneumoniae ST20 (n = 2).
The percentages of isolates with the extended-spectrum-β-lactamases CTX-M-15, blaCTX-M-14, blaTEM-1
were 9.4, 84.3, and 68.8 %, respectively. AmpC β-lactamase genes were not detected in our isolates.
Conclusions: KPC-2-positive K. pneumoniae ST11 and NDM-1-positive K. pneumoniae ST20 were associated with
this outbreak. The identification of these isolates in samples from radiant warmers and nurses suggests that
hospital cross-transmission played a role in this outbreak. Active infection control measures were effective for
controlling this multidrug-resistant K. pneumoniae outbreak.
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Background
Carbapenem-resistant Enterobacteriaceae (CRE) have
increasingly been found to cause nosocomial infections
during the past decade; they primarily affect critically ill
patients [1]. Carbapenem-resistant Klebsiella pneumoniae
(CR-KP) is one of the most important types of CRE, and it
has spread extensively around the world [2]. Carbapenems
are the most effective drug for treating infections caused
by K. pneumoniae that produce extended-spectrum
beta-lactamases (ESBLs). However, with the increase of
carbapenem resistance in K. pneumoniae, options for
treatment have become limited [3].
Carbapenemases, including KPC, GES, SME, NMC,
IMI NDM, IMP, VIM, and OXA-48, are the main
mechanisms of carbapenem resistance in CRE. Other
mechanisms of carbapenem resistance in these bacteria
include the absence or decreased expression of outer
membrane proteins and mutations in the ampC enzyme
or ESBLs [4].
Outbreaks of hospital-associated CRE infections are
not rare [5, 6]. In recent years, outbreaks of CRE infec-
tions in neonates have been rising and have attracted
increasingly more attention [7, 8]. Here, we noted
that the frequency of K. pneumoniae isolated from
newborns in our neonatal ward had dramatically increased
compared with that of previous years. Therefore, we
collected CR-KP in 2015 from January to November to
study the resistance and transmission mechanisms of
carbapenem-resistant strains in the neonatal ward.
Methods
Setting of the study
A retrospective study was conducted in an 11months
period between January 2015and November 2015 in the
neonatal ward of Tongji Hospital (TJH). The neonatal
ward of TJH receives approximately 1750 admissions
per year and it has six rooms (60 beds) for newborns.
The 60 % of patients come from maternity ward and
30 % of neonates were outpatients.
Bacterial isolates collection and identification
Thirty-two carbapenem-resistant K. pneumoniae were
included in this study. Twenty-seven isolates were
collected from different patients. At the same time,
according to previous investigation, hospital infection
control staff collected environmental samples from high
frequency contact areas in neonatal ward in September 8,
2015, including bed railing, stethoscope, personal digital
assistant, suction apparatus, venous catheter, radiant
warmer, nurses’ hand, thermostat button and ventilator
machine. Samplings were accomplished before routine
cleaning, 89 environmental samples and 40 samples from
nurses’ hands were obtained. All isolated strains were
identified by conventional biochemical methods, then
were confirmed by PCR amplification of 16S rRNA gene
and sequencing [9].
PCR and DNA sequence analysis of resistance gene
PCR were performed to detect drug-resistance genes,
including carbapenemases (blaKPC-2, blaGES, blaIMP-4,
blaVIM-1, blaNDM-1, blaOXA-48), common ESBL
genes (blaCTX-group1, blaCTX-group2, blaCTX-group8,
blaCTX-group9, blaTEM-1, and blaSHV), and ampC
genes (MOX, FOX, DHA, CIT, AAC and EBC) [10–12].
The PCR products were sequenced and analyzed using
BLAST (http://www.ncbi.nlm.nih.gov/BLAST).
Susceptibility testing
Antibiotic susceptibility testing was assayed by agar
dilution method to determinate the minimum inhibitory
concentration (MICs) of ampicillin, ceftazidime, cefota-
xime, cefepime, cefuroxime, cefoxitin, gentamicin, levo-
floxacin, amikacin, ciprofloxacin, aztreonam, imipenem,
meropenem, trimethoprim-sulfamethoxazole, piperacillin-
tazobactam, tigecycline and colistin. All antibiotics, except
tigecycline and colistin, were interpreted according to
the standard of the Clinical and Laboratory Standards
Institute (CLSI) document M100-S22. For tigecycline
and colistin, the European Committee on Antimicrobial
Susceptibility Testing (EUCAST) breakpoint was used.
E. coli ATCC 25922 and P.aeruginosa ATCC27853 were
used as quality control.
Multilocus sequence typing (MLST)
Epidemiological relatedness was carried out by multilocus
sequence typing (MLST). Multilocus sequence typing
(MLST) for clinical K. pneumoniae isolates was performed
following the methods described previously [13]. The
allelic profiles and sequence types (STs) were assigned
using online databases (http://www.pasteur.fr/recherche/
genopole/PF8/mlst/Kpneumoniae.html).
Infection control interventions
Strict infection control measures were implemented
according to the Guidance for Control of CRE in
November, 2015 [14]. Healthcare personnel are familiar
with proper hand hygiene technique and wash their hands
properly before entering and upon leaving patient rooms.
Hand hygiene adherence was monitored by video. Patients
who are suspected or confirmed with CRE should be
placed in a private room in which staff and visitors are
required to don gloves and gowns for entry. Extensive
cleaning of shared equipment and the use of disposable
materials (when feasible) were implemented.
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Results
Epidemiological characteristics of K. pneumoniae isolates
The molecular epidemiology of carbapenem-resistant
Enterobacteriaceae was studied from January to November
2015. During this period, There were 1519 patients
admitted to hospital,including 590 females (38.9 %)
and 929 males (61.1 %). The sex ratio of all patients
is similar to infection group (61.1 vs 63.0 %). The average
age of the CR-KP infection (32.5 ± 22.7) ws older
than all patients (11.2 ± 23.4).27 consecutive CRE were
isolated from 27 different patients. The characteristics
of the CR-KP isolated in this study are shown in
Table 1. Twenty seven of the isolates are from new-
borns in the neonatal unit, including 17 males and 10
females, with a mean age of 32.5 days (range, 1–85 days).
The sources of these specimens were blood (n = 9),
urine (n = 8), aspiration catheter (n = 5), and sputum
(n = 5). Meanwhile, ten suspicious colonies were found
and further identified by biochemical method, and
finally five CR-KP isolates were cultured from radiant
warmers or nurses’ hands during the peak of the
outbreak.
Table 1 Characteristics of multi-drug resistance K. pneumoniae
Isolate No. sex Specimen Date Of detection STs Carbapenemase ESBL
TJ1 F Sp 23/1/2015 ST11 KPC-2 CTX-14,TEM-1
TJ2 M Bl 1/2/2015 ST888 NDM-1 CTX-15,TEM-1
TJ3 M Ca 6/3/2015 ST11 KPC-2 CTX-14,TEM-1
TJ4 M Bl 7/3/2015 ST11 KPC-2 CTX-15
TJ5 M Sp 15/7/2015 ST11 KPC-2 CTX-14,TEM-1
TJ6 M Sp 16/7/2015 ST11 KPC-2 CTX-14
TJ7 F Ur 18/7/2015 ST20 NDM-1 TEM-1
TJ8 M Ca 4/8/2015 ST11 KPC-2 CTX-14
TJ9 M Ca 8/8/2015 ST11 KPC-2 CTX-14,TEM-1
TJ10 F Bl 11/8/2015 ST11 KPC-2 CTX-14,TEM-1
TJ11 M Ur 26/8/2015 ST11 KPC-2 CTX-14,TEM-1
TJ12 M Bl 31/8/2015 ST11 KPC-2 CTX-15
TJ13 M Bl 4/9/2015 ST11 KPC-2 CTX-14,TEM-1
TJ14 F Ca 13/9/2015 ST20 NDM-1 CTX-14,TEM-1
TJ15 M Sp 13/9/2015 ST11 KPC-2 CTX-14,TEM-1
TJ16 M Ca 22/9/2015 ST20 NDM-1 CTX-14
TJ17 F Sp 25/9/2015 ST11 KPC-2 CTX-14,TEM-1
TJ18 F Ur 30/9/2015 ST11 KPC-2 CTX-14,TEM-1
TJ19 M Bl 2/10/2015 ST11 KPC-2 CTX-14,TEM-1
TJ20 F Ur 6/10/2015 ST11 KPC-2 CTX-14,TEM-1
TJ21 M Ur 8/10/2015 ST11 KPC-2 CTX-14,TEM-1
TJ22 F Ur 12/10/2015 ST11 KPC-2 CTX-14,TEM-1
TJ23 M Bl 25/10/2015 ST11 KPC-2 –
TJ24 M Bl 28/10/2015 ST20 NDM-1 CTX-14
TJ25 F Ur 20/11/2015 ST11 KPC-2 CTX-14,TEM-1
TJ26 F Bl 20/11/2015 ST11 KPC-2 CTX-14
TJ27 M Ur 21/11/2015 ST11 KPC-2 CTX-14,TEM-1
TJ28a – Radiant warmer 8/9/2015 ST11 KPC-2 CTX-14,TEM-1
TJ29a – Radiant warmer 8/9/2015 ST20 NDM-1 CTX-14
TJ30b – Nurses hand 8/9/2015 ST11 KPC-2 CTX-14,TEM-1
TJ31c – Radiant warmer 8/9/2015 ST11 KPC-2 CTX-14,TEM-1
TJ32b – Nurses hand 8/9/2015 ST20 NDM-1 CTX-14
F female, M male, Sp sputum, BL blood, Ur urine, Ca aspiration catheter
a65 bed radiant warmer; bnurses hand; c55 bed radiant warmer
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Antimicrobial susceptibility patterns of K. pneumoniae
isolates
The results of minimum inhibitory concentration (MIC)
assays are shown in Table 2. All K. pneumoniae isolates
were non-susceptible to ampicillin, cefoxitin, cefuroxime,
cefotaxime, cefepime, ceftazidime, imipenem, meropenem,
and piperacillin tazobactam, but were highly sensitive
to tigecycline and colistin. The antibiotic resistance rates
to gentamicin, amikacin, levofloxacin, ciprofloxacin,
aztreonam, and trimethoprim-sulfamethoxazole were
78.1, 78.1, 78.1, 84.1, 78.1, and 21.9 %, respectively.
Notably, strains producing NDM-1carbapenemase show
different antibacterial susceptibility spectra from strains
producing KPC-2 carbapenemase, including gentamicin,
amikacin, levofloxacin, ciprofloxacin, aztreonam, and
trimethoprim-sulfamethoxazole (see Table 2).
Sequence typing and expression of drug-resistance genes
Based on the multi-locus sequence typing (MLST)
results, the 27 isolates from unique patients were identi-
fied as Sequence Type (ST) 11 (ST11) (n = 22), ST20
(n = 4), and ST888 (n = 1), and the five environmental
isolates were identified as ST11 (n = 3) and ST20 (n = 2).
The percentages of isolates with carbapenemases KPC-2
and NDM-1were 81.5 % (22/27) and 18.5 % (5/27),
respectively. All KPC-2-producing strains were ST11, and
most of the NDM-1-positive strains were ST20 (n = 4).
Three of the five environmental strains were KPC-2-
positive K. pneumoniae ST11, and the other two environ-
mental isolates were NDM-1-positive K. pneumoniae
ST20. The rates of the ESBLs CTX-M-15, CTX-M-14,
and TEM-1 were 9.4, 84.3, and 68.8 %, respectively. AmpC
genes and other carbapenemases were not detected.
The effect of infection control interventions
We monitored for neonatal infection with K. pneumoniae
in future 4 months, and we detected multidrug-resistant
K. pneumoniae in five patients, three patients, one patient
and one patient, respectively, over these 4 months.
Discussion
K. pneumoniae is an important nosocomial pathogen that
can cause pneumonia, sepsis, and meningitis [15]. The
emergence of CR-KP has created a challenge for treating
K. pneumoniae infections, the mortality caused by CR-KP
incection was high [16]. However, one infected neonate
has died in our study. Mortality from K. pneumoniae
infection is associated with a variety of factors, including
underlying disease, nutritional status, and medical treat-
ment, which may explain the discrepancy in mortality
among different studies.
Underlying disease, low birth weight, antibacterial
drug treatment, invasive procedures, and prolonged
hospitalization have all been reported as extremely
important risk factors of CRE infection [17, 18]. Of the 27
patients in this study, the percentages of subjects who had
a low birth weight, who were treated with antibacterial
drugs, and who underwent invasive procedures were
74.1 % (n = 20), 100 % (n = 27), and 77.8 % (n = 21)
(data was not show), respectively. Additionally, we
noticed that each nurse needed to take care of several
infants and that each newborn was usually cared for
by several nurses due to scheduling reasons. Overall,
the newborns in our study possessed high risk factors
for CRE infection, and this outbreak was likely spread
by cross-infection.
As results showed, no significant differences in sex
ratio and age between infection patients and non-infection
patients. The CR-KP infection probably has no relation
with age and gender in our study,which was similar
with other study [19]. In addition, the average days for
hospitalization in TJH is 11.8 days at present. However,
the average hospital stay of the 27 patients including in
this study was 29.9 days. Prolonged hospitalization may
contribute to spreading of the ST11 and ST20 strains in
neonatal ward.
Table 2 Antibiotic susceptibility of K. pneumoniae























AMP ampicillin (0.06–512), CAZ ceftazidime (0.06–512), CTX cefotaxime (0.06–512),
FEP cefepime (0.06–512), CXM cefuroxime (0.06–512), FOX cefoxitin (0.06–512),
GN gentamicin (0.06–512), LEV levofloxacin (0.06–512), AK amikacin (0.06–512),
CIP ciprofloxacin (0.004-32), ATM Aztreonam (0.06–512), IPM imipenem (0.03–256),
MEM meropenem (0.03–256), TZP piperacillin-tazobactam (0.25/4–256/4), SXT
trimethoprim-sulfamethoxazole (0.25/4.75–256/4864), TGC tigecycline (0.03–256),
CO colistin (0.03–256)
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The first KPC-2-producing K. pneumoniae isolate (TJ1)
was isolated from a 23-day-old boy that was confirmed
as infected with multidrug-resistant K. pneumoniae at
another hospital. He was transferred to our hospital for
treatment on January 23, 2015, and a sputum culture
confirmed his infection with a multidrug-resistant K.
pneumoniae. We learned that his mother had suffered
from a respiratory tract infection for 2 weeks and 4
days. Through combination therapy with cefoperazone
sulbactam, amoxicillin clavulanic acid, fluconazole, and
meropenem, the child recovered and was discharged on
February 5, 2015. Subsequently, KPC-2-positive strains
with the same phenotype appeared in the same ward.
All KPC-2-positive strains were detected in patients who
had been hospitalized for more than 48 h, so we speculate
that the origin of the KPC-2-positive K. pneumoniae ST11
was probably TJ1. Rodloff MD and his colleagues found
that carriage of KPC-2-producing K. pneumoniae can
last for 3 years [20]. It probably explain continuous
outbreak after index case. Regrettably, the origin of the
NDM-1-producing isolates in our study is still unknown.
The number of infection with K. pneumoniae decrease
sharply in future 4 months. These declining numbers
suggest that our efforts to control the continuous
outbreak of multidrug-resistant K. pneumoniae were at
least partially effective. However, there was one or two
CR-KP detected after infection control interventions. It is
difficult to eradicate the CR-KP by infection control
measures [21]. Infection control measures were still need
to improve, including routine screening of hospitalized
patients, pathogens culture of medical equipment and
screening the colonization status of contemporaneous
patients.
This study has several limitations. Specifically, we only
performed one environmental sampling and neglect
screening of patients with perianal swabs to detect the
rate of colonized patients. Additional samples might
have provided stronger evidence to support our conclu-
sion that the CR-KP was spread through cross-infection.
Our data is also unable to confirm whether or not the
CR-KP strains isolated in the later 3 months of our study
are the same as the previous epidemic strain.
Conclusions
In summary, we report that KPC-2-positive K. pneumoniae
ST11 and NDM-1-positive K. pneumoniae ST20 are the
two main clones that caused neonate infection in our
hospital during the study period. During the outbreak,
we successfully isolated these two main clones from a
radiant warmer and from nurses’ hands. The radiant
warmer and the nurses’ hands may have played an
important role in harboring the K. pneumoniae producing
KPC-2 or NDM-1 carbapenemases that caused persistent
infection within the same ward. Following the emergence
of CRE on a ward, Screening and infection control
measures must be implemented to block nosocomial
transmission. Active and effective infection control
measures are indispensable for preventing a subsequent
outbreak.
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